Integrated drug discovery and development services - tailored to your needs
23 February 2023
Throughout drug discovery and development, there are numerous scientific hoops to jump through to get a new, safe, and effective drug to improve people’s lives. Admescope has been part of the Symeres organization since late 2020; perhaps you are not aware about our integrated drug discovery (IDD) services with over 600 scientists who are available to support your projects from hit finding through preclinical development, until the first clinical studies. This blog post describes what you can access today, within our network, and how we operate to support our customers. We are excited to offer many more capabilities than standalone ADME-Tox/in vivo DMPK research provided by Admescope.Read more
Admescope 2022 lookback
31 January 2023
2022 was full of action, and it marked the most successful year to date in Admescope’s history. We are grateful to our customers who trusted us to perform their studies and are proud to say that we contributed to the highest ever number of drug discovery and development projects for customers across the continents.Read more
